Instituto Rosenbusch SA engages in the manufacture and marketing of veterinary products. It operates through the following business segments: Biological Products, Pharmaceutical Products, and Others. The Biological Products segment includes products for reproductive-respiratory complex, brucellosis and carbuncle, clostridial and other vaccines, horses, pneumonia and calve diarrhea, and queratoconjuntivitis. The Pharmaceutical Products segment includes antimastitics, antimicotics-bacteriostatics, endectocides, external antiparasitics, injectable antibiotics, internal antiparasitics, other chemotherapics, and vitamins and minerals. The company was founded in 1917 by Francisco Conrado Rosenbusch and is headquartered in Buenos Aires, Argentina.